Cargando…

Prevalence of frailty in China: Protocol for systematic review and meta-analysis

INTRODUCTION: China is facing more and more enormous challenges including aging, the increase of social security costs and health care cost, decrease of labors, and how to keep elders’ capacity to function well and live independently. Healthy aging has become an extremely challenging issue. Frailty,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qi, Lai, Honghao, Wang, Yunhua, Qi, Jing, Pan, Bei, Wang, Jiancheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254570/
https://www.ncbi.nlm.nih.gov/pubmed/32443317
http://dx.doi.org/10.1097/MD.0000000000020079
_version_ 1783539567047999488
author Wang, Qi
Lai, Honghao
Wang, Yunhua
Qi, Jing
Pan, Bei
Wang, Jiancheng
author_facet Wang, Qi
Lai, Honghao
Wang, Yunhua
Qi, Jing
Pan, Bei
Wang, Jiancheng
author_sort Wang, Qi
collection PubMed
description INTRODUCTION: China is facing more and more enormous challenges including aging, the increase of social security costs and health care cost, decrease of labors, and how to keep elders’ capacity to function well and live independently. Healthy aging has become an extremely challenging issue. Frailty, a geriatric syndrome resulted from the declines of multiple physiological systems, characterized by malnutrition, exercise intolerance, dependence, longer bed rest, lower gaits peed, weakness, weight loss, anorexia, hip fracture, risk of falling, delirium, dementia, and keep indoors, has become one of the biggest challenges in facilitating healthy aging. Because the research of frailty just had started in recent years in China, the evidence regarding the prevalence of frailty among the Chinese population is scarce and just limited in certain area. METHOD: We will systematically search 7 electronic database including PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of science, MEDLINE, CNKI (Chinese National Knowledge Infrastructure), and CBM (Chinese Biological Medical Database) to identify studies that provide or potential available of data regarding to prevalence of frailty. Risk of bias of individual study will be assessed using 8-iterm critical appraisal criteria for prevalence or incidence studies. Data will be analyzed using STATA V.12.0 software. CONCLUSIONS: Our systematic review and meta-analysis will firstly pool the results from available studies to provide a comprehensive evidence for the prevalence of frailty. The results of this study will be submitted to a peer-reviewed journal for publication.
format Online
Article
Text
id pubmed-7254570
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-72545702020-06-15 Prevalence of frailty in China: Protocol for systematic review and meta-analysis Wang, Qi Lai, Honghao Wang, Yunhua Qi, Jing Pan, Bei Wang, Jiancheng Medicine (Baltimore) 6600 INTRODUCTION: China is facing more and more enormous challenges including aging, the increase of social security costs and health care cost, decrease of labors, and how to keep elders’ capacity to function well and live independently. Healthy aging has become an extremely challenging issue. Frailty, a geriatric syndrome resulted from the declines of multiple physiological systems, characterized by malnutrition, exercise intolerance, dependence, longer bed rest, lower gaits peed, weakness, weight loss, anorexia, hip fracture, risk of falling, delirium, dementia, and keep indoors, has become one of the biggest challenges in facilitating healthy aging. Because the research of frailty just had started in recent years in China, the evidence regarding the prevalence of frailty among the Chinese population is scarce and just limited in certain area. METHOD: We will systematically search 7 electronic database including PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL), Web of science, MEDLINE, CNKI (Chinese National Knowledge Infrastructure), and CBM (Chinese Biological Medical Database) to identify studies that provide or potential available of data regarding to prevalence of frailty. Risk of bias of individual study will be assessed using 8-iterm critical appraisal criteria for prevalence or incidence studies. Data will be analyzed using STATA V.12.0 software. CONCLUSIONS: Our systematic review and meta-analysis will firstly pool the results from available studies to provide a comprehensive evidence for the prevalence of frailty. The results of this study will be submitted to a peer-reviewed journal for publication. Wolters Kluwer Health 2020-05-15 /pmc/articles/PMC7254570/ /pubmed/32443317 http://dx.doi.org/10.1097/MD.0000000000020079 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 6600
Wang, Qi
Lai, Honghao
Wang, Yunhua
Qi, Jing
Pan, Bei
Wang, Jiancheng
Prevalence of frailty in China: Protocol for systematic review and meta-analysis
title Prevalence of frailty in China: Protocol for systematic review and meta-analysis
title_full Prevalence of frailty in China: Protocol for systematic review and meta-analysis
title_fullStr Prevalence of frailty in China: Protocol for systematic review and meta-analysis
title_full_unstemmed Prevalence of frailty in China: Protocol for systematic review and meta-analysis
title_short Prevalence of frailty in China: Protocol for systematic review and meta-analysis
title_sort prevalence of frailty in china: protocol for systematic review and meta-analysis
topic 6600
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7254570/
https://www.ncbi.nlm.nih.gov/pubmed/32443317
http://dx.doi.org/10.1097/MD.0000000000020079
work_keys_str_mv AT wangqi prevalenceoffrailtyinchinaprotocolforsystematicreviewandmetaanalysis
AT laihonghao prevalenceoffrailtyinchinaprotocolforsystematicreviewandmetaanalysis
AT wangyunhua prevalenceoffrailtyinchinaprotocolforsystematicreviewandmetaanalysis
AT qijing prevalenceoffrailtyinchinaprotocolforsystematicreviewandmetaanalysis
AT panbei prevalenceoffrailtyinchinaprotocolforsystematicreviewandmetaanalysis
AT wangjiancheng prevalenceoffrailtyinchinaprotocolforsystematicreviewandmetaanalysis